Speaker programs are an important aspect of healthcare professional training and education; however, they also pose significant risk to your organization if not managed properly. In November 2020, a special fraud alert was issued by the Office of the Inspector General (OIG) highlighting the potential fraud and abuse related to the offer or payment of remuneration for speaker programs by pharmaceutical and medical device companies.
Listen as MediSpend’s Chief Legal and Privacy Officer, Tim Robinson, Esq., and MediSpend’s Compliance Attorney, Lauren Howe, analyze and review important takeaways from the OIG’s special fraud alert and recent settlement actions, as well as share methods to help your organization stay in compliance.
About MediSpend
MediSpend is a global technology company providing best-in-class solutions that enable life science companies to compliantly manage high-risk business functions through top-rated software and client services. MediSpend is the compliance system of record for some of the world’s largest pharmaceutical, medical device, dental and emerging biotech companies around the world. The MediSpend Global Compliance Suite represents the industry’s first global SaaS solution purpose-built to manage the end-to-end process of HCP engagement through transparency reporting, which includes software that facilitates external grant requests. MediSpend is headquartered in Portsmouth, N.H., with offices in Minnesota, New York, Pennsylvania and the Netherlands.